|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 12-14-2004
MELBOURNE (Reuters) - Australian biotech group Metabolic Pharmaceuticals Ltd. said on Monday a clinical trial showed its new weight-loss drug was effective and free of side effects, sending its shares soaring 28 percent.
WASHINGTON (Reuters) - Researchers said on Sunday they may have discovered what causes psoriasis, a common and irritating skin ailment, and said their findings may open the way to an effective treatment.
WASHINGTON (Reuters) - A new genetic test can tell doctors which breast cancer patients need to undergo the discomfort of chemotherapy -- and suggests many women don't need to, researchers said on Friday.
ZURICH (Reuters) - Aventis-Pasteur and Chiron Corp are due to start human testing of a vaccine against bird flu as early as this month, a World Health Organization official said on Saturday, to try to prevent a pandemic that could kill millions of people.
NEW YORK (Reuters Health) - Among patients treated at urban public hospital emergency rooms for skin and soft-tissue infections, more and more often the cause appears to be the antibiotic-resistant 'superbug' known as MRSA, new research shows.
NEW YORK (Reuters Health) - Approximately 65 percent of young children befriend imaginary companions, and nearly one-third continue to play with them through age 7, new research shows.
WASHINGTON (Reuters) - Pfizer Inc.'s painkiller Bextra will come with a new warning about the possibility of heart attacks and blood clots in patients who have just had heart bypass surgery, the U.S. Food and Drug Administration said on Thursday.
NEW YORK (Reuters Health) - Children with epilepsy have a moderately increased risk of dying early, but the cause of death is not usually related to seizures, investigators report. Rather, the increased risk appears to be more closely related to severe underlying conditions.
NEW YORK (Reuters Health) - Because adolescent girls with anorexia frequently develop hormonal, blood and bone density abnormalities, they require intensive clinical monitoring, according to a new report.
NEW YORK (Reuters Health) - Women with systemic lupus erythematosus (SLE) are more likely to have an abnormal Pap test result than other women, according to a new report. This is important because abnormal smears can be associated with cervical cancer.
|
|
